TB in 2021 - What's New? - Ribka Berhanu
Dr
Tb In 2021 What S New Ribka Berhanu PD2_6RtDjaE
In November of 2019 The National Department of health released the Rifampicin Resistant Clinincal Guide - a detailed reference ... Part of a series on...
Subclinical TB - Ribka Berhanu
Dr
TB Update 2026 - Ribka Berhanu
Ribka Berhanu
TB update 2024 - Ribka Berhanu
Dr
Tuberculosis VA Claims Explained: Ratings, Residuals, Case Law/Evidence Strategy (TB VA Claim Guide)
Tuberculosis
Discovering new drug targets for tuberculosis – Dr Del Besra
Dr Gurdyal 'Del' Besra
23 Heads of TB Laboratories from African Countries in Uganda to Learn About TB Treatment
23 Heads of
RRTB PART1: The diagnosis, classification of DRTB and WHO grouping of DRTB drugs. Nov 2019
In November of 2019 The National Department of health released the Rifampicin Resistant Clinincal Guide - a detailed reference ...
RRTB Part 3: ARVS and DRTB treatment.
Part of a series on tutorials on the Rifampicin Resistant Clinical Guideline released by the NDOH in November of 2019.
Tools for Accelerating Progress in Ending Tuberculosis: Lancet Commission on Tuberculosis 2023
Ask live questions here ...
TOP TUT: Rif Resistant TB
This tutorial touches on the key elements of the
Awareness to Action: Tuberculosis Part 1
World
Yes! We Can #EndTB! Shifting Attention to the Structural Drivers of Tuberculosis
As part of the Dahdaleh Institute Seminar Series 2022-2023, on March 22, and in celebration of World